Advertisement

Topics

TcLand Expression Product Pipeline Analysis, 2017 Update [Report Updated: 14072017] Prices from USD $750

22:51 EDT 20 Aug 2017 | BioPortfolio Report Blog

Summary

TcLand Expression TcLand is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multigenes molecular diagnostic blood tests. TcLand's clinical development programs include RAINFDx Test, IMD Dx2, IMD Dx3 and LTolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company TcLand Expression
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: TcLand Expression Product Pipeline Analysis, 2017 Update [Report Updated: 14072017] Prices from USD $750

NEXT ARTICLE

More From BioPortfolio on "TcLand Expression Product Pipeline Analysis, 2017 Update [Report Updated: 14072017] Prices from USD $750"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Gene Expression
The process of gene expression is used by eukaryotes, prokaryotes, and viruses to generate the macromolecular machinery for life. Steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-tran...